Drug · DIN 02130297
HALOPERIDOL LA
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 31, 2025; first marketed December 31, 1994.
- Drug Identification Number (DIN)
- 02130297
- Company (DIN owner)
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Liquid
- Route
- Intramuscular
- Therapeutic class (ATC)
- Haloperidol N05AD01
- Class
- Human
- Record last updated
- July 30, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| HALOPERIDOL (HALOPERIDOL DECANOATE) | 50 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 25, 2005: NOC 7330New Drug Submission (NDS) · Manufacturer name change
- September 21, 1994: NOC 5698New Drug Submission (NDS)
Other DINs named HALOPERIDOL LA
- DIN 02130300 · Marketed